CN104043061A - Traditional Chinese medicine (TCM) composition for treating chloasma - Google Patents
Traditional Chinese medicine (TCM) composition for treating chloasma Download PDFInfo
- Publication number
- CN104043061A CN104043061A CN201410316568.4A CN201410316568A CN104043061A CN 104043061 A CN104043061 A CN 104043061A CN 201410316568 A CN201410316568 A CN 201410316568A CN 104043061 A CN104043061 A CN 104043061A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- chloasma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine (TCM) composition for treating chloasma. The composition is prepared from the following active pharmaceutical ingredients in parts by weight: 11-13 parts of Indian bread, 11-13 parts of radix bupleuri, 11-13 parts of apricot kernels, 11-13 parts of pubescent holly root, 18-22 parts of salvia miltiorrhiza, 18-22 parts of prepared rehmannia root, 18-22 parts of Chinese yam, 18-22 parts of nacre, 6-8 parts of rhizoma sparganii, 6-8 parts of turmeric root tuber, 6-8 parts of asiatic cornelian cherry fruit, 6-8 parts of chrysanthemum, 6-8 parts of zedoray rhizome, 6-8 parts of virgate wormwood herb, 6-8 parts of safflower and 2-4 parts of mint. The composition has the advantages of stable curative effects and no side effects.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of chloasma.
Background technology
Chloasma also claims chloasma hepaticum, is facial yellowish-brown pigmentation.Multipair title butterfly is distributed in buccal.Be more common in women, in blood, estrogen level height is main cause, and its morbidity is relevant with gestation, Long-term Oral contraceptive, menoxenia.Also see the patients such as some female reproductive system illness, tuberculosis, cancer, chronic alcoholism, hepatopathy.Daylight can impel morbidity.Infringement, for yellowish-brown or dark brown patch, is often symmetrically distributed in cheekbone buccal, also can involve socket of the eye week, forehead, upper lip and nose, and edge is generally more obvious.Without subjective symptom and general malaise.The mottle depth and season, Exposure to Sunlight, endocrine factors is relevant.Psychentonia, stays up late, and fatigue can increase the weight of skin lesion.
At present, the medicine for the treatment of chloasma is more, but has the deficiencies such as curative effect is unstable, side effect is large.
Summary of the invention
The technical problem to be solved in the present invention is: for solving the deficiencies in the prior art, the invention provides a kind of Chinese medicine composition for the treatment of chloasma, the present invention has advantages of stable curative effect, has no side effect.
Treat a Chinese medicine composition for chloasma, by the crude drug of following weight portion, made: Poria 11-13 part, Radix Bupleuri 11-13 part, Semen Armeniacae Amarum 11-13 part, Radix Ilicis Pubescentis 11-13 part, Radix Salviae Miltiorrhizae 18-22 part, Radix Rehmanniae Preparata 18-22 part, Rhizoma Dioscoreae 18-22 part, Concha Margaritifera 18-22 part, Rhizoma Sparganii 6-8 part, Radix Curcumae 6-8 part, Fructus Corni 6-8 part, Flos Chrysanthemi 6-8 part, Rhizoma Curcumae 6-8 part, Herba Artemisiae Scopariae 6-8 part, Flos Carthami 6-8 part, Herba Menthae 2-4 part.
The Chinese medicine composition of described treatment chloasma, it is preferably made by the crude drug of following weight portion: 12 parts, Poria, 12 parts of Radix Bupleuri, 12 parts, Semen Armeniacae Amarum, 12 parts of Radix Ilicis Pubescentiss, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Radix Rehmanniae Preparata, 20 parts of Rhizoma Dioscoreaes, 20 parts of Concha Margaritiferas, 7 parts of Rhizoma Sparganii, 7 parts of Radix Curcumaes, 7 parts of Fructus Corni, 7 parts of Flos Chrysanthemis, 7 parts of Rhizoma Curcumae, 7 parts of Herba Artemisiae Scopariaes, 7 parts, Flos Carthami, 3 parts of Herba Menthaes.
The preparation method of the Chinese medicine composition of described treatment chloasma is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
The application of the Chinese medicine composition of described treatment chloasma in preparation treatment chloasma medicine.
The beneficial effect that the present invention compared with prior art had is: the present invention is under Traditional Chinese medical theory and clinical experience guidance, chooses each crude drug and proportioning thereof, has the function of heat-clearing and toxic substances removing, soothing the liver eliminating stagnation, realizes the object for the treatment of chloasma.
Below in conjunction with clinical experiment, beneficial effect of the present invention is described:
(1) clinical data: the present invention treats patient with chloasma 98 examples altogether, is all women, and the age is 25-55 year.
(2) Therapeutic Method: the oral drugs that Chinese medicine composition of the present invention is made can be decoction, tablet, pill and capsule etc., take decoction as example, 1 pair of every day, minute takes for 2 times, early, respectively take 1 evening, within 2 weeks, is 1 course for the treatment of.
(3) the standard of curative effect evaluation:
Cure: facial skin is the normal colour of skin.
Take a turn for the better: skin lesion disappears more than 30%.
Do not heal: skin lesion is without significant change, or the less than 30% that disappears.
(4) therapeutic outcome: the present invention treats patient with chloasma 98 examples altogether, through 1-4 course of therapy, cures 38 examples, accounts for 38.78%, and 54 examples that take a turn for the better, account for 55.1%, and 6 examples that do not heal, account for 6.12%, and effective percentage is 93.88%, has no any side effect; Cure in 38 examples, cure 5 examples 1 course for the treatment of, cure 8 examples 2 courses for the treatment of, cure 11 examples 3 courses for the treatment of, cure 14 examples 4 courses for the treatment of, follows up a case by regular visits to half by 1 year after healing, is showed no recurrence; Result shows, the present invention has advantages of stable curative effect, has no side effect.
(5) model case:
1, Xing, female, 31 years old, there is chloasma in face, and color is deepened gradually, spreads all over forehead, two cheeks, nose, mouthful periphery, is a lamellar, and symmetry occurs.Take Chinese medicine composition of the present invention after 2 courses for the treatment of, facial black speck has gone down half, continues to take Chinese medicine composition of the present invention and cures 2 courses for the treatment of, follows up a case by regular visits to, not recurrence after half a year.
2, Chen, female, 43 years old, buccal terrain figure shape yellowish-brown patch, companion's poor appetite, sleepy weak, uneasy sleeping at night, half congealed during stool.Preceeded menorrhea, many, the color of amount secretly have clot.Take Chinese medicine composition of the present invention after 1 course for the treatment of, brown patch color is thin out, continues to take Chinese medicine composition of the present invention and cures 2 courses for the treatment of, follows up a case by regular visits to, not recurrence after half a year.
3, Xu certain, female, 31 years old, there is chloasma in facial two cheeks, and increases the weight of year by year.Take Chinese medicine composition of the present invention after 1 course for the treatment of, chloasma starts to dissipate, and continues to take Chinese medicine composition of the present invention and cures 1 course for the treatment of, follows up a case by regular visits to, not recurrence after 1 year.
The specific embodiment
Embodiment 1:
Treat a Chinese medicine composition for chloasma, by the crude drug of following weight portion, made: 11 parts, Poria, 11 parts of Radix Bupleuri, 11 parts, Semen Armeniacae Amarum, 11 parts of Radix Ilicis Pubescentiss, 18 parts of Radix Salviae Miltiorrhizaes, 18 parts of Radix Rehmanniae Preparata, 18 parts of Rhizoma Dioscoreaes, 18 parts of Concha Margaritiferas, 6 parts of Rhizoma Sparganii, 6 parts of Radix Curcumaes, 6 parts of Fructus Corni, 6 parts of Flos Chrysanthemis, 6 parts of Rhizoma Curcumae, 6 parts of Herba Artemisiae Scopariaes, 6 parts, Flos Carthami, 2 parts of Herba Menthaes.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 2:
Treat a Chinese medicine composition for chloasma, by the crude drug of following weight portion, made: 12 parts, Poria, 12 parts of Radix Bupleuri, 12 parts, Semen Armeniacae Amarum, 12 parts of Radix Ilicis Pubescentiss, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Radix Rehmanniae Preparata, 20 parts of Rhizoma Dioscoreaes, 20 parts of Concha Margaritiferas, 7 parts of Rhizoma Sparganii, 7 parts of Radix Curcumaes, 7 parts of Fructus Corni, 7 parts of Flos Chrysanthemis, 7 parts of Rhizoma Curcumae, 7 parts of Herba Artemisiae Scopariaes, 7 parts, Flos Carthami, 3 parts of Herba Menthaes.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Embodiment 3:
Treat a Chinese medicine composition for chloasma, by the crude drug of following weight portion, made: 13 parts, Poria, 13 parts of Radix Bupleuri, 13 parts, Semen Armeniacae Amarum, 13 parts of Radix Ilicis Pubescentiss, 22 parts of Radix Salviae Miltiorrhizaes, 22 parts of Radix Rehmanniae Preparata, 22 parts of Rhizoma Dioscoreaes, 22 parts of Concha Margaritiferas, 8 parts of Rhizoma Sparganii, 8 parts of Radix Curcumaes, 8 parts of Fructus Corni, 8 parts of Flos Chrysanthemis, 8 parts of Rhizoma Curcumae, 8 parts of Herba Artemisiae Scopariaes, 8 parts, Flos Carthami, 4 parts of Herba Menthaes.
Its preparation method is: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
Claims (4)
1. a Chinese medicine composition for the treatment of chloasma, is characterized in that: the crude drug by following weight portion is made: Poria 11-13 part, Radix Bupleuri 11-13 part, Semen Armeniacae Amarum 11-13 part, Radix Ilicis Pubescentis 11-13 part, Radix Salviae Miltiorrhizae 18-22 part, Radix Rehmanniae Preparata 18-22 part, Rhizoma Dioscoreae 18-22 part, Concha Margaritifera 18-22 part, Rhizoma Sparganii 6-8 part, Radix Curcumae 6-8 part, Fructus Corni 6-8 part, Flos Chrysanthemi 6-8 part, Rhizoma Curcumae 6-8 part, Herba Artemisiae Scopariae 6-8 part, Flos Carthami 6-8 part, Herba Menthae 2-4 part.
2. the Chinese medicine composition for the treatment of chloasma according to claim 1, is characterized in that: the crude drug by following weight portion is made: 12 parts, Poria, 12 parts of Radix Bupleuri, 12 parts, Semen Armeniacae Amarum, 12 parts of Radix Ilicis Pubescentiss, 20 parts of Radix Salviae Miltiorrhizaes, 20 parts of Radix Rehmanniae Preparata, 20 parts of Rhizoma Dioscoreaes, 20 parts of Concha Margaritiferas, 7 parts of Rhizoma Sparganii, 7 parts of Radix Curcumaes, 7 parts of Fructus Corni, 7 parts of Flos Chrysanthemis, 7 parts of Rhizoma Curcumae, 7 parts of Herba Artemisiae Scopariaes, 7 parts, Flos Carthami, 3 parts of Herba Menthaes.
3. the preparation method of the Chinese medicine composition for the treatment of chloasma according to claim 1 and 2, is characterized in that: Chinese medicinal preparation method is routinely made and is suitable for medicinal oral drugs.
4. the application of the Chinese medicine composition for the treatment of chloasma according to claim 1 and 2 in preparation treatment chloasma medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410316568.4A CN104043061A (en) | 2014-07-06 | 2014-07-06 | Traditional Chinese medicine (TCM) composition for treating chloasma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410316568.4A CN104043061A (en) | 2014-07-06 | 2014-07-06 | Traditional Chinese medicine (TCM) composition for treating chloasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104043061A true CN104043061A (en) | 2014-09-17 |
Family
ID=51496784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410316568.4A Pending CN104043061A (en) | 2014-07-06 | 2014-07-06 | Traditional Chinese medicine (TCM) composition for treating chloasma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104043061A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105213668A (en) * | 2015-10-31 | 2016-01-06 | 孙太辉 | A kind of medicine for the treatment of chloasma faciei and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1857668A (en) * | 2006-03-20 | 2006-11-08 | 王信锁 | Chloasma treating Chinese medicine preparation |
-
2014
- 2014-07-06 CN CN201410316568.4A patent/CN104043061A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1857668A (en) * | 2006-03-20 | 2006-11-08 | 王信锁 | Chloasma treating Chinese medicine preparation |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105213668A (en) * | 2015-10-31 | 2016-01-06 | 孙太辉 | A kind of medicine for the treatment of chloasma faciei and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103800485A (en) | Traditional Chinese medicine preparation for treating herpes simplex keratitis | |
| CN103386008A (en) | Chinese medicine composition for treating endocrine dyscrasia | |
| CN103356916B (en) | Traditional Chinese medicinal composition for treating retrograde menstruation | |
| CN103721190B (en) | A kind of cyst type acne mixture | |
| CN103393913B (en) | Chinese medicinal composition for treating uterine prolapse | |
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN103341105A (en) | Traditional Chinese medicine preparation for treating infantile pertussis | |
| CN102512617B (en) | Chinese herbal preparation for treating psoriasis | |
| CN103212021A (en) | Traditional Chinese medicine composition used for treating chloasma | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN104645146A (en) | Chinese medicine composition for treating acne | |
| CN104042761A (en) | Traditional Chinese medicine (TCM) composition for treating herpes zoster | |
| CN103341037B (en) | Traditional Chinese medicine composition for treating azoospermia | |
| CN102139034A (en) | Medicament for treating chloasma | |
| CN104042896A (en) | Traditional Chinese medicinal composition for treating rosacea | |
| CN104138572A (en) | Medicine used for treating chloasma | |
| CN101843789A (en) | Chinese medicament for treating gout | |
| CN100444850C (en) | Chinese traditional medicine for treating skin diseases | |
| CN104043061A (en) | Traditional Chinese medicine (TCM) composition for treating chloasma | |
| CN103341111B (en) | Traditional Chinese medicine composition for treating spermatorrhea | |
| CN105641128A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN103800664A (en) | Traditional Chinese medicine composition for treating menopausal syndrome | |
| CN104383097A (en) | Traditional Chinese medicine for treating lupus erythematosus | |
| CN103736011B (en) | Injection care drug of a kind of cholesterol reducing and preparation method thereof | |
| CN103463412A (en) | Traditional Chinese medicinal composition for treating oral ulcer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140917 |
|
| RJ01 | Rejection of invention patent application after publication |